Tag Archives: BIO Events

Word on the Street – Biotech Stocks Only Have Room to Go Up

The Opening Lunch Plenary at this year’s BIO CEO & Investor Conference was a lively discussion between portfolio managers and senior buy-side analysts looking to forecast the year ahead in biotech. BIO’s own, Celia Economides, Director, Investor Relations & Programs, reminded us all where we were 15 years ago at the inception of this event. At the 1999 event, there were 18 presenting companies, zero 1X1 meetings scheduled and 271 attendees.  As of day one, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Celgene CEO on New Multiple Myeloma Drug Approvals

BIO CEO

Following on the heels of two big announcements in February, Celgene CEO Robert Hugin (one of FierceBiotech’s most influential people in biopharma) participated in a fireside chat with Joel Sendek, managing director and biotechnology analyst at Stifel Nicolaus & Company, at the 15th Annual BIO CEO & Investor Conference in New York. First, on Friday, February 8, the Food and Drug Administration (FDA) approved Celgene’s drug Pomalyst for patients with multiple myeloma whose disease has Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Simpson Bowles Keynote to Address Debt, Taxes, Government Services and Politics

Jim Greenwood

I was recently asked what the single biggest threat to the biotechnology industry is today.  My answer was immediate – the biggest threat to biotech innovation is the unsustainable mismatch of spending and revenue in the U.S. federal budget. The enormous national debt and the huge annual budget deficits that feed it endanger America’s entire economic future – but the nation’s dire fiscal situation is particularly threatening to our industry. Part of the reason for Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , ,

2013 BIO International Convention Program Highlights

John Flavin

I’m thrilled to be attending the upcoming 2013 BIO International Convention that is coming to Chicago April 22-25. The educational sessions, networking, business forum, and exhibits are coming together to form the strongest Convention to date. Of course, I may be biased being a Chicago native but I can’t think of a better venue and backdrop for the rapidly evolving biotechnology industry. The City of Chicago is known for its architects and novel designs, a Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

20th Anniversary of the BIO International Convention

Jim Greenwood

Next year BIO will celebrate the 20th anniversary of the BIO International Convention April 22-25 in Chicago. From a small beginning, our convention has grown into the most influential biotech meeting in the world, attracting more than 16,500 attendees from 65 countries and providing a wide array of education, exhibits and networking opportunities — including more than 25,000 partnering meetings expected during the 4-day event. As we look forward to the upcoming Convention, I cannot Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , ,